473 related articles for article (PubMed ID: 17264033)
41. Bone Growth Induction in Mucopolysaccharidosis IVA Mouse.
Rintz E; Herreño-Pachón AM; Celik B; Nidhi F; Khan S; Benincore-Flórez E; Tomatsu S
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373036
[TBL] [Abstract][Full Text] [Related]
42. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
[TBL] [Abstract][Full Text] [Related]
43. Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase.
Tomatsu S; Montaño AM; Gutierrez M; Grubb JH; Oikawa H; Dung VC; Ohashi A; Nishioka T; Yamada M; Yamada M; Tosaka Y; Trandafirescu GG; Orii T
Mol Genet Metab; 2007 May; 91(1):69-78. PubMed ID: 17336563
[TBL] [Abstract][Full Text] [Related]
44. Efficient CRISPR/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVA.
Leal AF; Alméciga-Díaz CJ
Gene Ther; 2023 Feb; 30(1-2):107-114. PubMed ID: 35581402
[TBL] [Abstract][Full Text] [Related]
45. [Analysis of GALNS gene mutation in thirty-eight Chinese patients with mucopolysaccharidosis type IVA].
Ye J; Lei HL; Zhang HW; Qiu WJ; Han LS; Wang Y; Li XY; Gu XF
Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):414-9. PubMed ID: 24120057
[TBL] [Abstract][Full Text] [Related]
46. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
Dvorak-Ewell M; Wendt D; Hague C; Christianson T; Koppaka V; Crippen D; Kakkis E; Vellard M
PLoS One; 2010 Aug; 5(8):e12194. PubMed ID: 20808938
[TBL] [Abstract][Full Text] [Related]
47. [Clinical, biologic and molecular characteristics of two Tunisian MPS IV A patients].
Khedhiri S; Chkioua L; Ferchichi S; Bouzidi H; Haj Khelil A; Ben Mansour R; Kassab A; M'dallah S; Chaabouni M; Jrad T; Ben Chibani J; Miled A; Laradi S
Ann Biol Clin (Paris); 2007; 65(1):59-63. PubMed ID: 17264040
[TBL] [Abstract][Full Text] [Related]
48. Biochemical defect of non-keratan-sulfate-excreting Morquio syndrome.
Fujimoto A; Horwitz AL
Am J Med Genet; 1983 Jun; 15(2):265-73. PubMed ID: 6224421
[TBL] [Abstract][Full Text] [Related]
49. Mucopolysaccharidosis IVA within Tunisian patients: Confirmation of the two novel GALNS gene mutations.
Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ferchichi S; Ben Turkia H; Miled A; Laradi S
Pathol Biol (Paris); 2012 Jun; 60(3):190-2. PubMed ID: 22078177
[TBL] [Abstract][Full Text] [Related]
50. Optimizing the molecular diagnosis of GALNS: novel methods to define and characterize Morquio-A syndrome-associated mutations.
Caciotti A; Tonin R; Rigoldi M; Ferri L; Catarzi S; Cavicchi C; Procopio E; Donati MA; Ficcadenti A; Fiumara A; Barone R; Garavelli L; Rocco MD; Filocamo M; Antuzzi D; Scarpa M; Mooney SD; Li B; Skouma A; Bianca S; Concolino D; Casalone R; Monti E; Pantaleo M; Giglio S; Guerrini R; Parini R; Morrone A
Hum Mutat; 2015 Mar; 36(3):357-68. PubMed ID: 25545067
[TBL] [Abstract][Full Text] [Related]
51. Plasma Proteomic Analysis in Morquio A Disease.
Álvarez JV; Bravo SB; Chantada-Vázquez MP; Barbosa-Gouveia S; Colón C; López-Suarez O; Tomatsu S; Otero-Espinar FJ; Couce ML
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200496
[TBL] [Abstract][Full Text] [Related]
52. Umbilical mesenchymal stem cell-derived extracellular vesicles as enzyme delivery vehicle to treat Morquio A fibroblasts.
Flanagan M; Pathak I; Gan Q; Winter L; Emnet R; Akel S; Montaño AM
Stem Cell Res Ther; 2021 May; 12(1):276. PubMed ID: 33957983
[TBL] [Abstract][Full Text] [Related]
53. Natural history of the oldest known females with mucopolysaccharidosis type IVA (Morquio A syndrome).
Peretz RH; Flora CH; Adams DJ
Am J Med Genet A; 2020 Jun; 182(6):1491-1495. PubMed ID: 32216080
[TBL] [Abstract][Full Text] [Related]
54. Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: the first national natural history cohort study.
Leong HY; Abdul Azize NA; Chew HB; Keng WT; Thong MK; Mohd Khalid MKN; Hung LC; Mohamed Zainudin N; Ramlee A; Md Haniffa MA; Yakob Y; Ngu LH
Orphanet J Rare Dis; 2019 Jun; 14(1):143. PubMed ID: 31200731
[TBL] [Abstract][Full Text] [Related]
55. Enhanced Efficiency of the Basal and Induced Apoptosis Process in Mucopolysaccharidosis IVA and IVB Human Fibroblasts.
Brokowska J; Gaffke L; Pierzynowska K; Węgrzyn G
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762422
[TBL] [Abstract][Full Text] [Related]
56. Morquio A syndrome-associated mutations: a review of alterations in the GALNS gene and a new locus-specific database.
Morrone A; Caciotti A; Atwood R; Davidson K; Du C; Francis-Lyon P; Harmatz P; Mealiffe M; Mooney S; Oron TR; Ryles A; Zawadzki KA; Miller N
Hum Mutat; 2014 Nov; 35(11):1271-9. PubMed ID: 25137622
[TBL] [Abstract][Full Text] [Related]
57. Novel missense mutation in the GALNS gene in an affected patient with severe form of mucopolysaccharidosis type IVA.
Seyedhassani SM; Hashemi-Gorji F; Yavari M; Mirfakhraie R
Clin Chim Acta; 2015 Oct; 450():121-4. PubMed ID: 26276046
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of HIV-1 derived lentiviral vectors as transductors of Mucopolysaccharidosis type IV a fibroblasts.
Puentes-Tellez MA; Sánchez OF; Rojas-Rodriguez F; Benincore-Flórez E; Barbosa H; Alméciga Díaz CJ
Gene; 2021 May; 780():145527. PubMed ID: 33636292
[TBL] [Abstract][Full Text] [Related]
59. Elosulfase alfa.
Haddley K
Drugs Today (Barc); 2014 Jul; 50(7):475-83. PubMed ID: 25101330
[TBL] [Abstract][Full Text] [Related]
60. Mucopolysaccharidosis IVA: Current Disease Models and Drawbacks.
Leal AF; Alméciga-Díaz CJ; Tomatsu S
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
